KESIMPULAN DAN SARAN
DAFTAR PUSTAKA
Afrose, R., Akram, M., Karimi, AM., Siddiqui, SA. 2015. Correlation of age and gender with different histological subtypes of primary lung cancer. Medical Journal of Dr. D.Y. Patil University, Vol 8; 447-451 Arand, M., Cronin, A,. Adamska, M., Oesch, F. 2005. Epoxide Hydrolases
: Structure, Function, Mechanism, and Assay. Methods in Mangunkusumo Jakarta Tahun 2011-2012. Fakultas Kesehatan Masyarakat, Universitas Indonesia.
Benhamou, S., Reinikainen, M., Bouchardy, C., Dayer, P. and Hirvonen, A. 1998. Association Between Lung Cancer and Microsomal Epoxide Hydrolase Genotypes. Cancer research, 58: 5291-5293.
Bryant. A.and Cerfalio, R.J. 2007. Differences in Epidemiology, Histology, and Survival Between Cigarette Smokers and Never-Smokers WHO Develop Non-Small Cell Lung Cancer. Chest, 185- 92 Christine, N. S. S. 2011. Hubungan Merokok dengan Kanker Paru di RSUP Haji Adam Malik Tahun 2009.IlmuKedokteranRespirasi, http://repository.usu.ac.id.
Danaei, G. 2005. Causes of Cancer in the World: Comparative Risk Assessment of Nine Behavioural and Environmental Risk Factors.
Lancet, 366:1784-93.
DeMarini. D. M. 2004. Genotoxicity of Tobacco Smoke and Tobacco Smoke Condensate: a review. Mutation Research, 567: 447–474 Ding, Y.S., Ashley D.L., Watson, C.H. 2007, Determination of 10
Carcinogenic Polycyclic Aromatic Hydrocarbons in Mainstream Cigarette Smoke, Journal of Agricultural and Food Chemistry, 55:
5966-5973.
[Depkes RI] Departemen Kesehatan RI, Riset Kesehatan Dasar.
2013.Kementerian Kesehatan Republik Indonesia, Jakarta,
El-Sherbeni, A.A. and El-Kadi, A.O.S. 2014. The Role of Epoxide Hydrolases in Health and Disease. Arch Toxicol, 88: 2013–2032.
Erkisi, Z., Eraltan, I.Y., Turna, A., Gormus, U., Canlica, H. et al. 2010.
Polymorphisms in the Microsomal Epoxide Hydrolase Gene : Role in Lung Cancer Susceptibility and Prognosis. Tumori, 96 : 756-763.
46
Fossella , F.V. 2003. Clinical Examination of Patients with Suspected Lung Cancer. In Buzdar A, Freedman RS Lung Cancer. Springer.
New York. 25-34.
GLOBOCAN. (2012). Section of Cancer Surveillance.
Gondodiputro, S. 2007. "Bahaya tembakau dan bentuk-bentuk sediaan tembakau." Bagian Ilmu Kesehatan Masyarakat Fakultas Kedokteran Universitas Padjadjar. dalam Mustikaningrum, S. 2010. Perbedaan kadar trigliserida darah pada perokok dan bukan perokok. Doctoral dissertation, Universits Sebelas Maret Fakultas Kedokteran
Graziano, C., Comin, C.E., Crisci, C., Novelli, L., Politi, L. et al. 2009.
Functional Polymorphisms of The Microsomal Epoxide Hydrolase Gene : A Reappraisal on a Early-onset Lung Cancer Patients Series : Lung Cancer. Elsevier, 63 : 187-193.
Gsur, A., Zidek, T., Schnattinger, K., Feik, E., Haidinger, G., Hollaus, P.
et al. 2003. Association of Microsomal Epoxide Hydrolase Polymorphisms and Lung Cancer Risk. British Journal of Cancer, 89:
702–706.
Guntulu, A.K., Metentas, M., Metintas, S., Yildirim, H., Erginel, S. and Alatas, F. 2007. Lung Cancer in Individuals Less Than 50 Years of Age. Lung, 185: 279-286
Hassett, C., Aicher, L., Sidhu, J.S. and Omiecinski, C.J. 1994. Human Microsomal Epoxide Hydrolase: Genetic Polymorphism and Functional Expression in Vitro of Amino Acid Variants. Hum Mol Genet. 3:421–428.
Hecht, S.S. 2002. Cigarette Smoking and Lung Cancer: Chemical Mechanisms and Approaches to Prevention. The lancet Oncology,3:
461–469.
Hecht, S. S. 2003. Tobacco Carcinogens, Their Biomarkers and Tobacco-Induced Cancer. Nature Reviews Cancer, 3: 733-744.
[IARC] International Agency for Research on Cancer. 2012. Lung Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012 Hoffmann, D., Hoffmann, I. 1997. The changing cigarette, 1950-1995. J
Toxicol Environ Health. ;50(4):307–64
Hulma, M.A., Basyar, M. dan Mulyani, H.2014. Hubungan Karakteristik Penderita dengan Gambaran Sitopatologi pada Kasus Karsinoma Paru yang Dirawat di RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas,3: 2
Josen, K., Siegel, R. and Kamp, D. I. 2002. Incidence and Epidemiology.
In Weitberg. A.B. Cancer of the Lung From Melecular Biology to Treatment Guidelines. New Jersey. Humana Press :3-26
47
Kafferlein, H. U., Marczynski, B., Mensing, T., and Bruning, T. 2010.
Albumin and Hemoglobin Adducts of benzo[a]pyrene in Humans—
Analytical Methods, Exposure Assessment, and Recommendations for Future Directions. Crit. Rev. Toxicol, 40: 126–150.
Kartika S, Aisah N, Bakhriansyah M. Profil Penderita Kanker Paru Primer di RSUD Ulin Banjarmasin Tahun 2006-2011. Berkelanjutan Kedokteran.2013; 9(2): 169-180.
[KPKN] Komite Nasional Penanganan Kanker. 2015. Panduan Nasional Penanganan Kanker Paru. Kementrian Kesehatan Republik Indonesia versi 1.0
Kirmani N, K Jamil, MUR Naidu. Occupational and environmental carcinogens in epidemiology of lung cancer in South Indian Population. Journal Biology and Medicine. 2010; 2(4)
Kiyohara, C., Yoshimasu, K., Takayama.,K. and Nakanishi, Y. 2006.
EPHX1 Polymorphisms and the Risk of Lung Cancer: a huge review.
Epidemiology,17: 89–99.
Kligerman S, Charles W. Epidemiology of lung cancer in women: risk factors, survival, and screening. American Journal of Roentgenology.
2010; 196(2).
Kumar, V., Anirban, M., 2004. Paru dan Saluran Nafas Atas : Buku Ajar Patologi. Penerbit Buku Kedokteran EGC
Kuschner, W.G. and Blanc, P.D. 2007. Gases & Other Airborne Toxicants. In J. Ladou (Eds), Occupational & Environmental Medicine, 4: 515-531
Kwack, S. J. and Lee, B. M. 2000. Correlation Between DNA or Protein Adducts and benzo[a]pyrene diol epoxide I-triglyceride Adduct Detected in Vitro and in Vivo. Carcinogenesis 21: 629–632.
Li, H., Fu, W. and Hong, Z., 2013. Microsomal Epoxide Hydrolase Gene Polymorphisms and Risk of Chronic Obstructive Pulmonary Disease : A Comprehensive meta-analysis. Oncology letters : 1022-1030.
Liang, G.Y., Pu, Y.P., and Yin, L.H. 2004. Studies of the Genes Related to Lung Cancer Susceptibility in Nanjing Han Population, China. Yi Chuan, 26:584–8.
Liu, H., Li, H.Y., Chen H.J., Huang Y.j., Zhang, S., Wang, J. 2013.
EPHX1 A139G Polimorphism and Lung Cancer Risk : a meta-analysis. Tumor Biol, 34 : 155-163.
Luch,A. 2010. Carcinogenic Polycyclic Aromatic Hydrocarbons. Institute for Risk Assesment, Berlin, Germany. Elsevier : 85-123.
48
Melindawati, Br.G., 2009. Karakteristik Penderita Kanker Paru Rawat Inap di RSUP H. Adam Malik Medan Tahun 2004-2008. Repository USU
Moorthy, B., Chu, C., Carlin, D.J. 2015. Polycyclic Aromatic Hydrocarbons : from Metabolism to Lung Cancer. Toxicological Sciences, 145 (1), 5-15.
Osgood, R.S., Upham, B.L., Hill, T .III., Helms, K.L., Velmuruga,. K., Babica. P. et al. 2013. Polycyclic Aromatic Hydrocarbon-Induced Signaling Events Relevant to Inflammation and Tumorigenesis in Lung Cells Are Dependent on Molecular Structure. PLOS ONE, 8;
Issue 6: e65150.
Park, J.Y., Chen, L., Elahi, A., Lazarus, P., and Tockman, M.S. 2005.
Genetic Analysis of Microsomal Epoxide Hydrolase Gene and its Association with Lung Cancer Risk. HIH Public Access. European Journal Cancer Prev, 14: 223-230.
[PDPI] Perhimpunan Dokter Paru Indonesia. 2011.Kanker Paru (Kanker Paru Jenis Karsinoma Bukan Sel Kecil). Pedoman Diagnosis &
Penatalaksanaan di Indonesia. Jakarta: PT. Metro Offset Printing ; p.2.
[PDPI] Perhimpunan Dokter Paru Indonesia. 2016.Kanker Paru, Pedoman Diagnosis & Penatalaksanaan di Indonesia. Jakarta: PT. Metro Offset Printing
Persson, I., Johansson, I., Lou, Y.C., Yue, Q.Y., Duan, L.S. et al. 1999.
Genetic Polymorphism of Xenobiotic Metabolizing Enzymes among Chinese Lung Cancer Parents. International Journal Cancer. 81 : 325-329.
Presiden Republik Indonesia. Peraturan Pemerintah No 109 tahun 2012 tentang Pengamanan Bahan yang Mengandung Zat Adiktif berupa produk tembakau bagi Kesehatan. Jakarta: Sekretaris Negara. 2012.
Rosenberger A, Thomas I, Katrin K, Norman K, Vera Z, Gabi W, et al. Do genetic factors protect for early onset lung cancer? a case control study before the age of 50 years. Journal of BMC Cancer 2008.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC229 2731/.)
Rotunno, M., Yu, K., Lubin, J.H., Consonni, D., Pesatori, A.C., Goldstein, A.M. et al. 2009. Phase 1 Metabolic Genes and Risk of Lung Cancer : Multiple Polymorphisms and mRNA Expression. Plos One, 4(5) :
49
Situmeang B. Karakteristik penderita kanker paru yang dirawat inap di RS.
St. Elisabeth Medan Tahun 2004-2007. Medan: Fakultas Kesehatan Masyarakat Universitas Sumatera Utara; 2008.
Soeroso, N.N., Soeroso, L., Syafiuddin, T. 2014. Kadar Carcinoembryogenic Antigen (CEA) Serum Penderita Kanker Paru Karsinoma Bukan Sel Kecil di RSUP Adam Malik. Departemen Pulmonologi dan Kedokteran Respirasi FK USU. J Respir Indo, 34:
17-25.
Syahruddin, E. 2010. Characteristic patients in Indonesian association for the study of lung cancer data. The 4th scientific respiratory medicine meeting. PIPKRA Departemen Pulmonologi dan Kedokteran Respirasi FKUI: 81-5
Tilak, A.R., Kumar, S., Jain, M., Pan, M.C., Das, B.C., Guleria, R. et al.
2011. Association of Functionally Important Polymorphism of Microsomal. Cancer Investigation, 29:6;411-418
Toh, C.K., Gao, F., Lim, W.T. 2006. Never-smokers with Lung Cancer:
Epidemiologic Evidence of a Distinct Disease Entity. J Clin Oncol, 24:2245-51.
[WHO] World Health Organization .2014. Tobacco.
Wu, X., Gwyn, K., Amos, C.I., Makan, N., Hong, W.H. et al. 2001. The Association of Microsomal Epoxide Hydrolase Polymorphisms and Lung Cancer Risk in African-Americans and Mexican-Americans.
Carcinogenesis, 22: 923-928.
Xu, X., Hua, H., Fan, B., Sun, Q., Guo, X. et al. 2015. EPHX1 rs2234922 Polymorphism and Lung Cancer Susceptibility in Asian Populations : a meta-analysis. Journal of Thoracic Disease 7(7) : 1125-1129.
Yu, W., Lin, Z., Qu, B. 2015. Impact of Epoxide Hydrolase 1 Polymorphisms on Lung Cancer Susceptibility in Asian Populations.
Cell Biochem Biophys. Springer, 71: 813-820.
Zakaria, FR. 2001. Pangan dan Pencegahan Kanker. Jurnal Teknologi dan Industri Pangan, XII:171-176.
Zhou, W., Thurston, S.W., Liu, G., Xu, L.L., Miller, D.D. et al. 2001. The Interaction between Microsomal Epoxide Hydrolase Polymorphisms and Cumulative Cigarette Smoking in Different Histological Subtypes of Lung Cancer. Cancer Epidemiol Biomarkers, 10: 461-466.
50
LAMPIRAN 1